NCT04011865 is a NA clinical trial of Radical prostatectomy in Prostate Cancer, sponsored by Binh Dan Hospital.

Who is sponsoring NCT04011865?

NCT04011865 is sponsored by Binh Dan Hospital.

What drugs are being tested in NCT04011865?

Interventions in NCT04011865: Radical prostatectomy.

What condition does NCT04011865 study?

NCT04011865 studies Prostate Cancer.

Is NCT04011865 still recruiting?

NCT04011865 is currently status unknown. Last updated 14 July 2020.

Last reviewed 2020-07-14 · How we verify

NCT04011865

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer Treatment

Status unknown NA Last updated 14 July 2020

What this trial tests

NA trial testing Radical prostatectomy in Prostate Cancer in 80 participants. Status unknown.

Timeline

1 January 2019

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Binh Dan Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	1 January 2019
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across Vietnam

Drugs / interventions tested

Radical prostatectomy

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →

Sponsor

Binh Dan Hospital

Who can join

18 and older, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to compare the outcomes of robotic-assisted laparoscopic radical prostatectomy (RARP) and laparoscopic radical prostatectomy (LRP) for prostate cancer treatment in terms of perioperative surgical, functional and oncological outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Radical prostatectomy

Trials testing the same drug.

NCT07490210 — Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer · Phase 2 · not yet recruiting
NCT07439913 — Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatect · enrolling by invitation
NCT07163910 — Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinic · Phase 2 · recruiting
NCT06844513 — Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform · NA · not yet recruiting
NCT06430411 — Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study · not yet recruiting

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other Binh Dan Hospital trials

Trials by the same sponsor.

NCT07038954 — Evaluation of Stone Composition in Surgical Kidney Stone Patients in Vietnam · completed
NCT03931980 — Robotic Versus Laparoscopic Approach for Rectal Cancer Surgery · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04011865 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Binh Dan Hospital
Last refreshed: 14 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04011865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing